According to Gram Research analysis, high-fat diets worsen ulcerative colitis by shutting down a protective cellular process called AMPK in gut cells, causing fat to accumulate, damaging energy-producing structures (mitochondria), and weakening the intestinal barrier. A 2026 study in mice found that reactivating AMPK with a drug called AICAR reversed this damage, suggesting a potential new treatment approach for inflammatory bowel disease patients.
A new study reveals how eating too much fat can trigger a chain reaction that damages your gut and worsens inflammatory bowel disease. Researchers found that high-fat diets shut down a protective cellular process called AMPK, which normally helps your gut cells burn fat efficiently. When this process stops working, fat builds up inside gut cells, damages their energy-producing structures (mitochondria), and weakens the barrier that keeps harmful bacteria out. The good news: activating AMPK with a drug called AICAR reversed this damage in mice, suggesting a potential new treatment approach for people with ulcerative colitis.
Key Statistics
A 2026 research article published in PLOS ONE found that high-fat diet feeding significantly exacerbated colitis in mice, with the damage mediated by suppression of the AMPK/PPARα pathway that normally helps gut cells burn fat efficiently.
In the 2026 study, pharmacological activation of AMPK using AICAR effectively reversed intestinal epithelial damage, restored fatty acid oxidation capacity, and ameliorated intestinal barrier dysfunction in mice with high-fat diet-induced colitis.
The 2026 research demonstrated that high-fat diet-induced suppression of AMPK led to decreased expression of key mitochondrial respiratory chain proteins (NDUFS2 and MTCO2), ultimately resulting in cellular energy depletion that compromised gut barrier integrity.
According to the 2026 study, high-fat feeding triggered both intestinal epithelial lipid accumulation and gut microbiota dysbiosis, which synergistically activated oxidative stress while paradoxically suppressing the protective AMPK phosphorylation pathway.
The Quick Take
- What they studied: How eating a high-fat diet makes ulcerative colitis (a type of gut inflammation) worse, and what happens inside gut cells when this occurs
- Who participated: Laboratory mice fed a high-fat diet combined with a chemical that triggers colitis, plus human intestinal cells grown in dishes and exposed to fatty acids and bacterial toxins
- Key finding: High-fat diets turn off a protective cellular switch called AMPK in gut cells, which causes fat to accumulate, damages the cell’s energy factories (mitochondria), and breaks down the gut barrier that protects against infection
- What it means for you: If you have ulcerative colitis or inflammatory bowel disease, reducing dietary fat may help reduce symptoms. More importantly, this research points toward new treatments that could reactivate the AMPK pathway to repair gut damage, though human testing is still needed
The Research Details
Researchers used two complementary approaches to understand how high-fat diets damage the gut. First, they fed mice a high-fat diet and then exposed them to a chemical that triggers colitis symptoms, monitoring weight loss, disease severity, and tissue damage. Second, they grew human intestinal cells in laboratory dishes and exposed them to palmitic acid (a saturated fat) and lipopolysaccharide (a bacterial toxin) to mimic what happens in the gut during inflammation. They then used microscopy to visualize cellular damage and molecular techniques to measure changes in specific proteins and pathways. Finally, they tested whether activating AMPK with a drug called AICAR could reverse the damage.
This approach is important because it bridges the gap between what happens in living organisms and what happens at the cellular level. By using both mice and human cells, the researchers could confirm that their findings apply across species. Testing a potential treatment (AICAR) in this system provides early evidence that targeting the AMPK pathway might work in humans, though much more research is needed before clinical trials
This study uses established animal models of colitis and human cell lines, making the findings reasonably reliable for understanding basic mechanisms. However, mice don’t always respond the same way humans do, so results need confirmation in human studies. The research was published in PLOS ONE, a peer-reviewed journal, which means other scientists reviewed the work. The study’s main limitation is that it’s exploratory research designed to uncover mechanisms, not to test whether treatments work in people
What the Results Show
High-fat diet feeding significantly worsened colitis in mice, causing rapid weight loss and severe intestinal tissue damage. The researchers discovered that this damage occurred through a specific molecular pathway: the high-fat diet suppressed a protective protein called AMPK (adenosine monophosphate-activated protein kinase) in gut cells. When AMPK becomes inactive, it can no longer activate another protein called PPARα, which normally helps cells burn fat efficiently. Without PPARα working properly, fat accumulates inside gut cells, creating a toxic environment. This fat buildup damages mitochondria, the structures inside cells that produce energy (ATP). When mitochondria are damaged, cells can’t produce enough energy to maintain the intestinal barrier, the protective lining that keeps harmful bacteria out of the bloodstream. The result is a breakdown of this barrier, allowing bacterial toxins to trigger inflammation and worsen colitis symptoms. Importantly, when researchers used a drug called AICAR to artificially activate AMPK, it reversed all of these problems: fat accumulation decreased, mitochondrial function improved, and the intestinal barrier strengthened.
The study also found that high-fat diets altered the composition of gut bacteria (dysbiosis), which contributed to inflammation. Additionally, the researchers observed that high-fat feeding increased oxidative stress, meaning an imbalance between harmful free radicals and protective antioxidants. The combination of altered bacteria, oxidative stress, and fat accumulation created a perfect storm that overwhelmed the gut’s defenses. Interestingly, the AMPK inactivation appeared paradoxical: the researchers expected AMPK to be activated in response to stress, but instead it was suppressed, suggesting that high-fat diet and bacterial toxins actively shut down this protective pathway
This research builds on existing knowledge that high-fat diets worsen inflammatory bowel disease and that mitochondrial dysfunction plays a role in colitis. However, this study provides new detail about the specific molecular pathway connecting these observations. Previous research showed that AMPK is important for gut health, but this is among the first studies to demonstrate that high-fat diets specifically suppress AMPK in intestinal cells and that this suppression is a key driver of colitis progression. The finding that AICAR can reverse this damage is novel and suggests a new therapeutic target
This study was conducted in mice and cell cultures, not humans, so results may not directly translate to people with ulcerative colitis. The sample size of mice was not specified in the abstract, making it difficult to assess statistical power. The study used a specific type of mouse (C57BL/6) and a specific chemical (DSS) to trigger colitis, which may not perfectly mimic human disease. The research focused on one molecular pathway (AMPK/PPARα) and may not capture all the ways high-fat diets damage the gut. Finally, while AICAR reversed damage in this experimental system, it has not been tested in humans with ulcerative colitis, so we don’t know if it would be safe or effective as a treatment
The Bottom Line
For people with ulcerative colitis or inflammatory bowel disease, reducing saturated fat intake may help reduce disease severity, though this study doesn’t provide specific dietary targets. This is a moderate-confidence recommendation based on mechanistic evidence in animals. For the general population, this research reinforces existing advice to limit high-fat diets for overall gut health. High-confidence recommendation: do not self-treat with AICAR or other AMPK activators without medical supervision, as this research is preliminary. Speak with a gastroenterologist about dietary modifications tailored to your specific condition
This research is most relevant to people with ulcerative colitis, Crohn’s disease, or other inflammatory bowel conditions. It may also interest people with metabolic disorders like obesity or type 2 diabetes, since AMPK dysfunction is implicated in these conditions too. People without gut disease can use this as motivation to moderate fat intake, though they should not assume they have the same risks. Healthcare providers treating inflammatory bowel disease should be aware of this mechanistic pathway when counseling patients about diet
If dietary fat reduction is implemented, improvements in gut symptoms might appear within weeks to months, though this timeline is based on general clinical experience, not this specific study. If AICAR or similar drugs are eventually developed for human use, they would likely need to be taken regularly to maintain benefits. Long-term dietary changes typically show the most sustained benefits over months to years
Frequently Asked Questions
Does eating a high-fat diet cause ulcerative colitis?
High-fat diets don’t directly cause ulcerative colitis, but research shows they significantly worsen symptoms in people who already have the condition. A 2026 study found that high-fat diets suppress a protective cellular pathway (AMPK) in gut cells, allowing fat to accumulate and damage the intestinal barrier
What is AMPK and why does it matter for gut health?
AMPK is a cellular protein that acts like a master switch controlling how cells use energy and burn fat. When AMPK is active, it helps gut cells efficiently process fatty acids and maintain a healthy intestinal barrier. High-fat diets suppress AMPK, disrupting this protective function
Can reducing fat intake help control ulcerative colitis symptoms?
Research suggests that reducing saturated fat intake may help reduce colitis severity, though individual responses vary. A 2026 study showed that high-fat diets worsen gut inflammation through specific molecular pathways, supporting dietary fat reduction as a potential management strategy alongside medical treatment
Is AICAR a treatment I can use for inflammatory bowel disease?
AICAR is not currently approved for treating inflammatory bowel disease. The 2026 study showed it reversed damage in mice, but human clinical trials are needed before it could become a treatment. Do not self-treat with AICAR without medical supervision
How does mitochondrial damage relate to gut inflammation?
Mitochondria are the energy factories inside cells. When high-fat diets damage mitochondria in gut cells, those cells can’t produce enough energy to maintain the intestinal barrier. A weakened barrier allows bacterial toxins to trigger inflammation, worsening colitis symptoms
Want to Apply This Research?
- Log daily dietary fat intake (grams of saturated fat) alongside symptom severity scores (abdominal pain, diarrhea frequency, blood in stool on a 0-10 scale) to identify personal correlations between fat consumption and flare-ups
- Set a daily saturated fat limit (for example, under 20 grams per day) and use the app to identify high-fat foods to avoid or reduce, such as fatty meats, full-fat dairy, and fried foods. Replace these with lean proteins, fish, and plant-based fats
- Track weekly averages of fat intake and symptom scores over 8-12 weeks to identify patterns. Share this data with your healthcare provider to determine if dietary modification is helping your specific condition
This research describes mechanisms in mice and laboratory cell cultures, not proven treatments in humans. If you have ulcerative colitis or inflammatory bowel disease, consult your gastroenterologist before making significant dietary changes or considering any new treatments. Do not use AICAR or other AMPK activators without medical supervision. This article is for educational purposes and should not replace professional medical advice. Individual responses to dietary modifications vary, and what works for one person may not work for another.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.